From: Dupuytren’s disease and the risk of malignant neoplasms
Tumor site | Males from Dupuytren’s disease families | Population (males)# | Females from Dupuytren’s disease families | Population (females)# | ||||
---|---|---|---|---|---|---|---|---|
Frequency | Mean age at diagnosis (yrs) | Frequency | Mean age at diagnosis (yrs) | Frequency | Mean age at diagnosis (yrs) | Frequency | Mean age at diagnosis (yrs) | |
(%) | (%) | (%) | (%) | |||||
Breast | 0 | ND^ | 0,2 | 64,1 | 28,8 | 56,95 | 22,4 | 60,2 |
Lungs | 21,8 | 65,38 | 21,1 | 65,9 | 4,32 | 63,33 | 8,6 | 65,1 |
Colorectal | 13,3 | 70,21 | 12,4 | 67,2 | 7,91 | 65,64 | 10,1 | 68,3 |
Stomach | 10,3 | 63,88 | 4,9 | 66,4 | 3,6 | 65,8 | 2,7 | 68,6 |
Prostate | 13,9 | 68,91 | 13,2 | 70,1 | - | - | - | - |
Kidney | 3,03 | 65,8 | 4,1 | 63 | 4,32 | 63,67 | 2,8 | 65,2 |
Larynx | 6,67 | 64,64 | 2,7 | 62,4 | 0 | ND^ | 0,4 | 62,2 |
Skin | 3,64 | 67,5 | 6,8 | 69,3 | 1,44 | ND^ | 7,5 | 70,2 |
Leukaemia | 3,03 | 57,38 | 2,2 | 56,9 | 2,88 | ND^ | 1,9 | 62 |
CNS | 7,88 | 56,38 | 2,4 | 55,3 | 7,91 | 62,45 | 2,3 | 59,3 |
Pancreas | 2,42 | ND^ | 2,3 | 64,7 | 5,04 | 70,43 | 2,3 | 69,2 |
Uterus | - | - | - | - | 4,32 | 54,5 | 7,3 | 63,6 |
FGT* | - | - | - | - | 12,2 | 57,94 | 17,8 | 68,8 |